The 6 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 387.50, with a high estimate of 449.00 and a low estimate of 330.00. The median estimate represents a +57.36% increase from the last price of 246.25.
The current consensus among 9 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $2.13
Reporting Date Oct 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.